However, in a relatively large number of patients with end-stage HF, we found a significant upregulation of LV SGLT1 mRNA and protein expression compared with controls which was accompanied by unaltered AMPK phosphorylation, whereas ERK1/2 activation was significantly lower [41]. The gene discussed is SLC5A1; the disease is hydrops fetalis.